Raphas Co., Ltd. (KOSDAQ:214260)

Market Cap	130.33B
Revenue (ttm)	28.04B
Net Income (ttm)	-4.45B
Shares Out	8.41M
EPS (ttm)	-502.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,658
Average Volume	20,755
Open	15,170
Previous Close	15,070
Day's Range	14,980 - 15,250
52-Week Range	12,500 - 23,400
Beta	1.23
RSI	52.89
Earnings Date	Aug 14, 2025

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was founded in 2006 and is headquartered in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 79
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.